Filing Details
- Accession Number:
- 0001415889-19-000308
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-12 20:50:57
- Reporting Period:
- 2019-03-11
- Accepted Time:
- 2019-03-12 20:50:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1386570 | Chromadex Corp. | CDXC | Medicinal Chemicals & Botanical Products (2833) | 262940963 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1437237 | Jr L Frank Jaksch | 10900 Wilshire Blvd. Suite 650 Los Angeles CA 90024 | Executive Chairman Of Board | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-03-11 | 33,334 | $1.50 | 234,891 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-03-11 | 14,390 | $3.50 | 220,501 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Options (right to buy) | Disposition | 2019-03-11 | 33,334 | $0.00 | 33,334 | $1.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2010-05-13 | 2019-05-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 2,075,052 | Indirect | By Black Sheep, FLP |
Footnotes
- The shares were sold to cover the cost of the exercise of the options which were scheduled to expire on May 13, 2019.
- The weighted average sale price for the transaction reported was $3.50, and the range of prices were between $3.47 and $3.53. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.